507 related articles for article (PubMed ID: 36026526)
1. The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.
Palmnäs-Bédard MSA; Costabile G; Vetrani C; Åberg S; Hjalmarsson Y; Dicksved J; Riccardi G; Landberg R
Am J Clin Nutr; 2022 Oct; 116(4):862-874. PubMed ID: 36026526
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies.
Letchumanan G; Abdullah N; Marlini M; Baharom N; Lawley B; Omar MR; Mohideen FBS; Addnan FH; Nur Fariha MM; Ismail Z; Pathmanathan SG
Front Cell Infect Microbiol; 2022; 12():943427. PubMed ID: 36046745
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
5. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
6. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Feng QQ; Ojo OO; Wang XH
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
[TBL] [Abstract][Full Text] [Related]
7. The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre.
Salamone D; Rivellese AA; Vetrani C
Acta Diabetol; 2021 Sep; 58(9):1131-1138. PubMed ID: 33970303
[TBL] [Abstract][Full Text] [Related]
8. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
Nogal A; Valdes AM; Menni C
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
[TBL] [Abstract][Full Text] [Related]
9. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: Can SCFAs play a role?
Vitale M; Giacco R; Laiola M; Della Pepa G; Luongo D; Mangione A; Salamone D; Vitaglione P; Ercolini D; Rivellese AA
Clin Nutr; 2021 Feb; 40(2):428-437. PubMed ID: 32698959
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
12. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
13. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Oat Consumption, Gut Microbiota Modulation, and Short-Chain Fatty Acid Synthesis: An Integrative Review.
Fabiano GA; Shinn LM; Antunes AEC
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630725
[TBL] [Abstract][Full Text] [Related]
15. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
[No Abstract] [Full Text] [Related]
16. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
[TBL] [Abstract][Full Text] [Related]
17. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus.
Fassatoui M; Lopez-Siles M; Díaz-Rizzolo DA; Jmel H; Naouali C; Abdessalem G; Chikhaoui A; Nadal B; Jamoussi H; Abid A; Gomis R; Abdelhak S; Martinez-Medina M; Kefi R
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31147456
[TBL] [Abstract][Full Text] [Related]
19. Insulin Sensitivity-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes (db/db) Mice.
Mei X; Zhang X; Wang Z; Gao Z; Liu G; Hu H; Zou L; Li X
J Agric Food Chem; 2016 Oct; 64(40):7502-7511. PubMed ID: 27635781
[TBL] [Abstract][Full Text] [Related]
20. Shotgun metagenomics reveals abnormal short-chain fatty acid-producing bacteria and glucose and lipid metabolism of the gut microbiota in patients with schizophrenia.
Li Z; Qing Y; Cui G; Li M; Liu T; Zeng Y; Zhou C; Hu X; Jiang J; Wang D; Gao Y; Zhang J; Cai C; Wang T; Wan C
Schizophr Res; 2023 May; 255():59-66. PubMed ID: 36965360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
